Vision Genomics, LLC

Vision Genomics, LLC Vision genomics, LLC is a biotechnology-based company that focuses on research and development of therapeutics for age-related eye diseases.

Our company undertakes an interdisciplinary approach using big data analysis to produce working solutions for age-related eye diseases. Our primary disease of interest is Age-related macular degeneration (AMD). AMD is the leading cause of visual impairment and blindness in older adults and one of the most common causes of visual impairment worldwide. Vision Genomics, LLC is focused on operations a

nd development of its AMD Medicine drug discovery with a personalized medicine platform. AMD Medicine was developed using the advanced genomic and transcriptomic analysis algorithms already successfully used in cancer research and precision medicine in oncology. The AMD Medicine platform contains broad databases of gene expression, genetic and epigenetic data in ocular diseases as databases of drugs with known molecular targets and effects on gene expression in a variety of tissues and cell lines. It includes advanced parametric and machine learning algorithms that screen for drugs that minimize the difference between healthy and disease states while targeting signaling pathways that are pathologically activated or down regulated and accounting for pharmacogenomic effects. Our company focuses on development of geroprptectors for AMD using such interdisciplinary technology.

01/28/2017

Right now, about 120,000 Americans are on a waiting list for an organ transplant and 22 will die today before any organs become available. The plain truth is there aren’t enough organ donors to mee…

10/27/2016

October is Blindness Awareness month. In honor of the patients who suffer from diseases of blindness and of the scientists and doctors who work tirelessly to develop treatments and cures for these …

https://www.sciencedaily.com/releases/2016/09/160919084604.htm
09/20/2016

https://www.sciencedaily.com/releases/2016/09/160919084604.htm

At the back of the retina in adult vertebrate eyes is a highly differentiated layer of cells known as the retinal pigment epithelium (RPE). These cells do not normally multiply or migrate in adults, but in humans they do so in response to retinal trauma. They then pass through a transitional state o...

09/05/2016

The government's National Eye Institute is committing $12.4 million to research technologies that can regenerate damaged neurons.

https://www.sciencedaily.com/releases/2016/08/160825084849.htm
08/28/2016

https://www.sciencedaily.com/releases/2016/08/160825084849.htm

A major therapeutic challenge, the retinal prostheses that have been under development during the past ten years can enable some blind subjects to perceive light signals, but the image thus restored is still far from being clear. By comparing in rodents the activity of the visual cortex generated a...

http://newatlas.com/eye-test-retinal-changes-parkinsons/44970/
08/22/2016

http://newatlas.com/eye-test-retinal-changes-parkinsons/44970/

�An ability to detect Parkinson's before it imparts irreparable damage on the brain would be a game changer when it comes to treatment. New research has raised the prospect of a low-cost eye test to catch the disease before it evolves into telltale symptoms like tremors and muscle stiffness.

08/09/2016

From spotting galaxies millions of light years away to perceiving invisible colours, Adam Hadhazy explains why your eyes can do incredible things.

08/08/2016

Reports assert that Japanese doctors have, for the first time in history, used artificial intelligence to detect a type of leukemia, which helped to save a patient's life.

Address

Washington D.C., DC
20059

Website

Alerts

Be the first to know and let us send you an email when Vision Genomics, LLC posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category